Skip to content

Dr. Kimberly Parmentier

Active Private limited companyfounded 2021active for 4 yearsVrijeigen 3, 8540 DeerlijkKBO/BCE: BE 0778.546.447

Lifetime

4 annual accounts with figures on one time axis
peak of €142,961 in 2024
€125,608▼ 12.1%
peak of €105,392 in 2024
€92,001▼ 12.7%
peak of €274,345 in 2024
€5,346▼ 98.1%
€107,702▲ 14×
Board1 name since 2021
1 director
Documentsfilings and deeds
18-08-202618 days late
2025micro format
Gross margin from €142,961 to €125,608Dividend €361,000Equity from €274,345 to €5,346Debts from €7,849 to €107,702Cash from €234,930 to €81,738

Key points

from the 2025 annual accounts

Equity

€5,346 from €274,345 in 2024

Equity fell by 98% in 1 year.

Turnover

≈ €230,000 estimated

The micro format states no turnover.

Debts

€107,702 95% of the balance sheet
Suppliers 11%Taxes and wages 5%Other 84%

Liquidity

0.85 was 31.91 in 2024

Short-term debts rose from €7,849 to €107,702.

Filings

4 annual accounts 3 late
AprilJune31 JulyOctober2022202320242025

The 2023 accounts came in latest, 29 days after the end of the period.

Position in the sector

€5,346

Less equity than 90% of companies in human health. Sector median €125,088 · 21,349 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,155 companies had the same profile as Dr. Kimberly Parmentier has now. Each dot stands for 6 companies, two years later.

94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,155 companies, not a prediction for Dr. Kimberly Parmentier. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 15-12-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0778546447
Incorporation Founding capital of €5,000, 100 shares · Founded by · appointed as director · published on 15-12-2021 · Gazette deed
First establishment Vrijeigen 3, Deerlijk
All 11 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Kimberly Parmentier Deerlijk €113,049 €125,608 4.7% -
Lienwit Jabbeke €107,541 €136,092 96.6% -
Dr. Lieve Vercammen Holsbeek €105,927 €126,211 89.2% -
Huisarts K. Leeten Diest €121,545 €119,891 72.9% -
Dr. Sam Delvaux Leuven €125,425 €126,108 70.3% -
Dr. Saskia Gruijthuijsen Hoogstraten €115,100 €115,974 84.3% -
Dr. B. Blancke, huisarts Brecht €99,624 €125,567 47.5% -

These companies have the same main activity as Dr. Kimberly Parmentier: general medical practice (NACE 86210). They are comparable in size and age: total assets between €99,600 and €125,000, founded between 2021 and 2022.

Official details

Source: KBO
Status
Active since 13-12-2021Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.325.079.8058540 Deerlijk, since 13-12-2021
Financial year end
31 December
Peppol
Reachable since 11-04-2025
Company details

Annual accounts 2025

€113,049▼ 59.9%
Filing
Filed on 18-08-2026
Financials

Insights on Dr. Kimberly Parmentier

Dr. Kimberly Parmentier files the micro format. That format states no turnover. The gross margin rose from €110,162 in 2022 to €125,608 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Kimberly Parmentier

What is the company number of Dr. Kimberly Parmentier?
The company number of Dr. Kimberly Parmentier is 0778.546.447. The VAT number is the same number with BE in front: BE 0778.546.447.
Where is Dr. Kimberly Parmentier based?
The registered office is at Vrijeigen 3, 8540 Deerlijk.Company details
What does Dr. Kimberly Parmentier do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Kimberly Parmentier?
Dr. Kimberly Parmentier is a private limited company (BV).
When was Dr. Kimberly Parmentier founded?
Dr. Kimberly Parmentier was founded on 13-12-2021.
Is Dr. Kimberly Parmentier still active?
Yes, Dr. Kimberly Parmentier is an active enterprise in the KBO register.
What is the turnover of Dr. Kimberly Parmentier?
The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €125,608 and 30 comparable companies (NACE 86210). It probably lies between €180,000 and €280,000.Financials
Is Dr. Kimberly Parmentier profitable?
In financial year 2025, Dr. Kimberly Parmentier made a profit of €92,001.
Where can I find the annual accounts of Dr. Kimberly Parmentier?
Dr. Kimberly Parmentier filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Kimberly Parmentier due?
Dr. Kimberly Parmentier must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.